drugset / Trial / NCT06560515

Dinoprostone Versus Vaginal Misoprostol for Induction of Labour

NCT06560515

Completed 370 enrolled University of Alexandria
RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized controlled study was carried out on 370 pregnant women with gestational age ≥ 40 weeks of different ages and parities at El-Shatby Maternity University Hospital after approval of ethical committee of Alexandria Faculty of Medicine. After assessment for eligibility \& enrollment in the study, women were randomly assigned into one of the two study groups, Group (I) received 3 mg vaginal Dinoprostone of maximum 2 doses 6 hours apart and Group (II) received 50 μg of vaginal misoprostol of maximum 2 doses 6 hours apart.

Timeline

Start
2022-08-01
Primary completion
2023-07-31
Completion
2023-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Other

Indications

No indication recorded.